• AdelsteinDJLiYAdamsGL. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol2003;21:9298.

    • Search Google Scholar
    • Export Citation
  • AdelsteinDJRidgeJAGillisonML. Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science MeetingNovember 9–10, 2008Washington, D.C.Head Neck2009;31:13931422.

    • Search Google Scholar
    • Export Citation
  • Al-SarrafMLeBlancMGiriPG. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol1998;16:13101317.

    • Search Google Scholar
    • Export Citation
  • BernierJCooperJSPajakTF. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck2005;27:843850.

    • Search Google Scholar
    • Export Citation
  • BernierJDomengeCOzsahinM. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med2004;350:19451952.

    • Search Google Scholar
    • Export Citation
  • BourhisJOvergaardJAudryH. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet2006;368:843854.

    • Search Google Scholar
    • Export Citation
  • BrizelDMAlbersMEFisherSR. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med1998;338:17981804.

    • Search Google Scholar
    • Export Citation
  • ColevasAD. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol2006;24:26442652.

    • Search Google Scholar
    • Export Citation
  • CooperJSPajakTFForastiereAA. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med2004;350:19371944.

    • Search Google Scholar
    • Export Citation
  • DeVitaVTJrLawrenceTSRosenbergSA eds. Cancer: Principles & Practice of Oncology8th edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.

    • Search Google Scholar
    • Export Citation
  • FuKKPajakTFTrottiA. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys2000;48:716.

    • Search Google Scholar
    • Export Citation
  • FurnissCSMcCleanMDSmithJF. Human papillomavirus 16 and head and neck squamous cell carcinoma. Int J Cancer2007;120:23862392.

  • GillisonMLKochWMCaponeRB. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst2000;92:709720.

    • Search Google Scholar
    • Export Citation
  • KutlerDIPatelSGShahJP. The role of neck dissection following definitive chemoradiation. Oncology (Williston Park)2004;18:993998; discussion 999 1003–1004 1007.

    • Search Google Scholar
    • Export Citation
  • LaurieSALicitraL. Systemic therapy in the palliative management of advanced salivary gland cancers. J Clin Oncol2006;24:26732678.

  • LefebvreJLChevalierDLuboinskiB. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst1996;88:890899.

    • Search Google Scholar
    • Export Citation
  • PiccirilloJF. Importance of comorbidity in head and neck cancer. Laryngoscope2000;110:593602.

  • PignonJPBourhisJDomengeC. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet2000;355:949955.

    • Search Google Scholar
    • Export Citation
  • RosenthalDITrottiA. Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol2009;19:2934.

  • VermorkenJBMesiaRRiveraF. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med2008;359:11161127.

  • 1

    DeVitaVJrLawrenceTRosenbergS eds. Cancer: Principles & Practice of Oncology8th edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.

    • Search Google Scholar
    • Export Citation
  • 2

    JemalASiegelRXuJWardE. Cancer statistics, 2010. CA Cancer J Clin2010;60:277300.

  • 3

    American Cancer Society. Cancer Facts & Figures 2010. Atlanta: American Cancer Society; 2010. Available at: http://www.cancer.org/downloads/STT/Cancer_Facts_and_Figures_2010.pdf. Accessed April 12 2011.

    • Search Google Scholar
    • Export Citation
  • 4

    GillisonMLKochWMCaponeRB. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst2000;92:709720.

    • Search Google Scholar
    • Export Citation
  • 5

    KreimerARCliffordGMBoylePFranceschiS. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev2005;14:467475.

    • Search Google Scholar
    • Export Citation
  • 6

    ApplebaumKMFurnissCSZekaA. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst2007;99:18011810.

    • Search Google Scholar
    • Export Citation
  • 7

    D’SouzaGKreimerARViscidiR. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med2007;356:19441956.

  • 8

    SchlechtNFBurkRDAdrienL. Gene expression profiles in HPV-infected head and neck cancer. J Pathol2007;213:283293.

  • 9

    SturgisEMCinciripiniPM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?Cancer2007;110:14291435.

    • Search Google Scholar
    • Export Citation
  • 10

    AdelsteinDJRidgeJAGillisonML. Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science MeetingNovember 9–10, 2008Washington, D.C.Head Neck2009;31:13931422.

    • Search Google Scholar
    • Export Citation
  • 11

    ChaturvediAKEngelsEAAndersonWFGillisonML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol2008;26:612619.

    • Search Google Scholar
    • Export Citation
  • 12

    EdgeSByrdDComptonC. AJCC Cancer Staging Manual7th ed.New York, NY: Springer; 2010.

  • 13

    GreeneFPageDFlemingI. AJCC Cancer Staging Manual6th ed.New York, NY: Springer-Verlag; 2002.

  • 14

    ColasantoJMPrasadPNashMA. Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology (Williston Park)2005;19:371379.

    • Search Google Scholar
    • Export Citation
  • 15

    SchnollRAZhangBRueM. Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol2003;21:355365.

    • Search Google Scholar
    • Export Citation
  • 16

    GritzERCarrCRRapkinD. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev1993;2:261270.

    • Search Google Scholar
    • Export Citation
  • 17

    FeinsteinAR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis1970;23:455468.

  • 18

    CharlsonMEPompeiPAlesKLMacKenzieCR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis1987;40:373383.

    • Search Google Scholar
    • Export Citation
  • 19

    PiccirilloJF. Importance of comorbidity in head and neck cancer. Laryngoscope2000;110:593602.

  • 20

    PiccirilloJFLacyPDBasuASpitznagelEL. Development of a new head and neck cancer-specific comorbidity index. Arch Otolaryngol Head Neck Surg2002;128:11721179.

    • Search Google Scholar
    • Export Citation
  • 21

    PiccirilloJF. Impact of comorbidity and symptoms on the prognosis of patients with oral carcinoma. Arch Otolaryngol Head Neck Surg2000;126:10861088.

    • Search Google Scholar
    • Export Citation
  • 22

    ChenAYMatsonLKRobertsDGoepfertH. The significance of comorbidity in advanced laryngeal cancer. Head Neck2001;23:566572.

  • 23

    SinghBBhayaMSternJ. Validation of the Charlson comorbidity index in patients with head and neck cancer: a multiinstitutional study. Laryngoscope1997;107:14691475.

    • Search Google Scholar
    • Export Citation
  • 24

    HallSFRochonPAStreinerDL. Measuring comorbidity in patients with head and neck cancer. Laryngoscope2002;112:19881996.

  • 25

    HallSFGroomePARothwellD. The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck. Head Neck2000;22:317322.

    • Search Google Scholar
    • Export Citation
  • 26

    RibeiroKCKowalskiLPLatorreMR. Impact of comorbidity, symptoms, and patients’ characteristics on the prognosis of oral carcinomas. Arch Otolaryngol Head Neck Surg2000;126:10791085.

    • Search Google Scholar
    • Export Citation
  • 27

    de GraeffAde LeeuwJRRosWJ. Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck2000;22:398407.

    • Search Google Scholar
    • Export Citation
  • 28

    FunkGFKarnellLHWhiteheadS. Free tissue transfer versus pedicled flap cost in head and neck cancer. Otolaryngol Head Neck Surg2002;127:205212.

    • Search Google Scholar
    • Export Citation
  • 29

    FarwellDGReillyDFWeymullerEA. Predictors of perioperative complications in head and neck patients. Arch Otolaryngol Head Neck Surg2002;128:505511.

    • Search Google Scholar
    • Export Citation
  • 30

    KaplanMHFeinsteinAR. The importance of classifying initial co-morbidity in evaluatin the outcome of diabetes mellitus. J Chronic Dis1974;27:387404.

    • Search Google Scholar
    • Export Citation
  • 31

    BangDPiccirilloJLittenbergB. The Adult Comorbidity Evaluation-27 (ACE-27) test: a new comorbidity index for patients with cancer [abstract]. J Clin Oncol2000;(Suppl 1):Abstract 1701.

    • Search Google Scholar
    • Export Citation
  • 32

    PiccirilloJCostasIClaybourP. The measurement of comorbidity by cancer registries. J Registry Manag2003;30:814.

  • 33

    PatrickDEricksonP. Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation. New York, NY: Oxford University Press; 1993.

    • Search Google Scholar
    • Export Citation
  • 34

    YuehB. Measuring and Reporting Quality of Life in Head and Neck Cancer. McLeanVirginia; 2002.

  • 35

    RogersSNGwanneSLoweD. The addition of mood and anxiety domains to the University of Washington quality of life scale. Head Neck2002;24:521529.

    • Search Google Scholar
    • Export Citation
  • 36

    BjordalKHammerlidEAhlner-ElmqvistM. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol1999;17:10081019.

    • Search Google Scholar
    • Export Citation
  • 37

    CellaD. Manual for the Functional Assessment of Cancer Therapy (FACT) Measurement System (version 4). Chicago: Rush Medical Center; 1997.

    • Search Google Scholar
    • Export Citation
  • 38

    ListMAD’AntonioLLCellaDF. The Performance Status Scale for head and neck cancer patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity. Cancer1996;77:22942301.

    • Search Google Scholar
    • Export Citation
  • 39

    HarrisonLSessionsRHongW. Head and Neck Cancer: A Multidisciplinary Approach3rd edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2009.

    • Search Google Scholar
    • Export Citation
  • 40

    RobbinsKTShahaARMedinaJE. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg2008;134:536538.

    • Search Google Scholar
    • Export Citation
  • 41

    ByersRM. Neck dissection: concepts, controversies, and technique. Semin Surg Oncol1991;7:913.

  • 42

    StringerSP. Current concepts in surgical management of neck metastases from head and neck cancer. Oncology (Williston Park)1995;9:547554.

    • Search Google Scholar
    • Export Citation
  • 43

    RobbinsKTClaymanGLevinePA. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg2002;128:751758.

    • Search Google Scholar
    • Export Citation
  • 44

    CandelaFCKothariKShahJP. Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx. Head Neck1990;12:197203.

    • Search Google Scholar
    • Export Citation
  • 45

    CandelaFCShahJJaquesDPShahJP. Patterns of cervical node metastases from squamous carcinoma of the larynx. Arch Otolaryngol Head Neck Surg1990;116:432435.

    • Search Google Scholar
    • Export Citation
  • 46

    ShahJPCandelaFCPoddarAK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer1990;66:109113.

    • Search Google Scholar
    • Export Citation
  • 47

    FerlitoARinaldoASilverCE. Elective and therapeutic selective neck dissection. Oral Oncol2006;42:1425.

  • 48

    SchmitzSMachielsJPWeynandB. Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol2009;266:437443.

    • Search Google Scholar
    • Export Citation
  • 49

    PatelRSClarkJWytenR. Squamous cell carcinoma from an unknown head and neck primary site: a “selective treatment” approach. Arch Otolaryngol Head Neck Surg2007;133:12821287.

    • Search Google Scholar
    • Export Citation
  • 50

    SivanandanRKaplanMJLeeKJ. Long-term results of 100 consecutive comprehensive neck dissections: implications for selective neck dissections. Arch Otolaryngol Head Neck Surg2004;130:13691373.

    • Search Google Scholar
    • Export Citation
  • 51

    LiauwSLMancusoAAAmdurRJ. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol2006;24:14211427.

    • Search Google Scholar
    • Export Citation
  • 52

    PorcedduSVJarmolowskiEHicksRJ. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck2005;27:175181.

    • Search Google Scholar
    • Export Citation
  • 53

    YaoMSmithRBHoffmanHT. Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report. Int J Radiat Oncol Biol Phys2009;74:914.

    • Search Google Scholar
    • Export Citation
  • 54

    LangoMNMyersJNGardenAS. Controversies in surgical management of the node-positive neck after chemoradiation. Semin Radiat Oncol2009;19:2428.

    • Search Google Scholar
    • Export Citation
  • 55

    IslesMGMcConkeyCMehannaHM. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol2008;33:210222.

    • Search Google Scholar
    • Export Citation
  • 56

    CorryJPetersLFisherR. N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98.02. Head Neck2008;30:737742.

    • Search Google Scholar
    • Export Citation
  • 57

    LauHPhanTMackinnonJMatthewsTW. Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg2008;134:257261.

    • Search Google Scholar
    • Export Citation
  • 58

    OngSCSchoderHLeeNY. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. J Nucl Med2008;49:532540.

    • Search Google Scholar
    • Export Citation
  • 59

    NayakJVWalvekarRRAndradeRS. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT. Laryngoscope2007;117:21292134.

    • Search Google Scholar
    • Export Citation
  • 60

    AbgralRQuerellouSPotardG. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?J Nucl Med2009;50:2429.

    • Search Google Scholar
    • Export Citation
  • 61

    BernierJDomengeCOzsahinM. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med2004;350:19451952.

    • Search Google Scholar
    • Export Citation
  • 62

    CooperJSPajakTFForastiereAA. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med2004;350:19371944.

    • Search Google Scholar
    • Export Citation
  • 63

    BernierJCooperJSPajakTF. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck2005;27:843850.

    • Search Google Scholar
    • Export Citation
  • 64

    BachaudJMCohen-JonathanEAlzieuC. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys1996;36:999104.

    • Search Google Scholar
    • Export Citation
  • 65

    ShahJPCendonRAFarrHWStrongEW. Carcinoma of the oral cavity. factors affecting treatment failure at the primary site and neck. Am J Surg1976;132:504507.

    • Search Google Scholar
    • Export Citation
  • 66

    LooserKGShahJPStrongEW. The significance of “positive” margins in surgically resected epidermoid carcinomas. Head Neck Surg1978;1:107111.

    • Search Google Scholar
    • Export Citation
  • 67

    JohnsonJTBarnesELMyersEN. The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol1981;107:725729.

  • 68

    FeldmanMFletcherGH. Analysis of the parameters relating to failures above the clavicles in patients treated by postoperative irradiation for squamous cell carcinomas of the oral cavity or oropharynx. Int J Radiat Oncol Biol Phys1982;8:2730.

    • Search Google Scholar
    • Export Citation
  • 69

    MirimanoffROWangCCDoppkeKP. Combined surgery and postoperative radiation therapy for advanced laryngeal and hypopharyngeal carcinomas. Int J Radiat Oncol Biol Phys1985;11:499504.

    • Search Google Scholar
    • Export Citation
  • 70

    PetersLJGoepfertHAngKK. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys1993;26:311.

    • Search Google Scholar
    • Export Citation
  • 71

    ThamesHDJrWithersHRPetersLJFletcherGH. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys1982;8:219226.

    • Search Google Scholar
    • Export Citation
  • 72

    WithersHThamesHPetersL. Differences in the fractionation response of acutely and late-responding tissues. In: KaercherKKogelnikHReinartzG eds. Progress in Radio-Oncology II. Vol. 11. New York, NY: Raven Press; 1982:287296.

    • Search Google Scholar
    • Export Citation
  • 73

    WithersHRTaylorJMMaciejewskiB. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol1988;27:131146.

  • 74

    HarwoodARBealeFACummingsBJ. T4NOMO glottic cancer: an analysis of dose-time volume factors. Int J Radiat Oncol Biol Phys1981;7:15071512.

    • Search Google Scholar
    • Export Citation
  • 75

    AmornmarnRPrempreeTViravathanaT. A therapeutic approach to early vocal cord carcinoma. Acta Radiol Oncol1985;24:321325.

  • 76

    SchwaiboldFScariatoANunnoM. The effect of fraction size on control of early glottic cancer. Int J Radiat Oncol Biol Phys1988;14:451454.

    • Search Google Scholar
    • Export Citation
  • 77

    KimRYMarksMESalterMM. Early-stage glottic cancer: importance of dose fractionation in radiation therapy. Radiology1992;182:273275.

  • 78

    ParsonJ. Time-dose-volume relationships in radiation therapy. In: MillionRCassisiN eds. Management of Head and Neck Cancer: A Multidisciplinary Approach2nd ed.Philadelphia, PA: Lippincott Williams & Wilkins; 1994:203243.

    • Search Google Scholar
    • Export Citation
  • 79

    HoriotJCLe FurRN’GuyenT. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol1992;25:231241.

    • Search Google Scholar
    • Export Citation
  • 80

    HoriotJC. [Controlled clinical trials of hyperfractionated and accelerated radiotherapy in otorhinolaryngologic cancers]. Bull Acad Natl Med1998;182:12471260; discussion 1261 [in French].

    • Search Google Scholar
    • Export Citation
  • 81

    HoriotJCBontempsPvan den BogaertW. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol1997;44:111121.

    • Search Google Scholar
    • Export Citation
  • 82

    FuKKPajakTFTrottiA. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys2000;48:716.

    • Search Google Scholar
    • Export Citation
  • 83

    TrottiAFuKPajakT. Long term outcomes of RTOG 90-03: a comparison of hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma [abstract]. Int J Radiat Oncol Biol Phys2005;63:S7071.

    • Search Google Scholar
    • Export Citation
  • 84

    BourhisJOvergaardJAudryH. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet2006;368:843854.

    • Search Google Scholar
    • Export Citation
  • 85

    BudachVStuschkeMBudachW. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol2005;23:11251135.

    • Search Google Scholar
    • Export Citation
  • 86

    BudachWHehrTBudachV. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer2006;6:28.

    • Search Google Scholar
    • Export Citation
  • 87

    BensadounRJBenezeryKDassonvilleO. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: results at 2 years (FNCLCC-GORTEC). Int J Radiat Oncol Biol Phys2006;64:983994.

    • Search Google Scholar
    • Export Citation
  • 88

    BrizelDMAlbersMEFisherSR. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med1998;338:17981804.

    • Search Google Scholar
    • Export Citation
  • 89

    JeremicBShibamotoYMilicicB. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol2000;18:14581464.

    • Search Google Scholar
    • Export Citation
  • 90

    AngKZhangQWheelerRH. A phase III trial (RTOG 0129) of two radiation-cisplatin regimens for head and neck carcinomas (HNC): impact of radiation and cisplatin intensity on outcome [abstract]. J Clin Oncol2010;28(Suppl 15):Abstract 5507.

    • Search Google Scholar
    • Export Citation
  • 91

    DenisFGaraudPBardetE. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol2004;22:6976.

    • Search Google Scholar
    • Export Citation
  • 92

    DenisFGaraudPBardetE. Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. Int J Radiat Oncol Biol Phys2003;55:9398.

    • Search Google Scholar
    • Export Citation
  • 93

    BourhisJCalaisGLapeyreM. Concomitant radiochemotherapy or accelerated radiotherapy: analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC). Semin Oncol2004;31:822826.

    • Search Google Scholar
    • Export Citation
  • 94

    MachtayMMoughanJTrottiA. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol2008;26:35823589.

    • Search Google Scholar
    • Export Citation
  • 95

    HartfordACPaliscaMGEichlerTJ. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for intensity-modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys2009;73:914.

    • Search Google Scholar
    • Export Citation
  • 96

    HolmesTDasRLowD. American Society of Radiation Oncology recommendations for documenting intensity-modulated radiation therapy treatments. Int J Radiat Oncol Biol Phys2009;74:13111318.

    • Search Google Scholar
    • Export Citation
  • 97

    WuQManningMSchmidt-UllrichRMohanR. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys2000;46:195205.

    • Search Google Scholar
    • Export Citation
  • 98

    ChaoKSMajhailNHuangCJ. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol2001;61:275280.

    • Search Google Scholar
    • Export Citation
  • 99

    DoganNKingSEmamiB. Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing. Int J Radiat Oncol Biol Phys2003;57:14801491.

    • Search Google Scholar
    • Export Citation
  • 100

    LiYTaylorJMTen HakenRKEisbruchA. The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy. Int J Radiat Oncol Biol Phys2007;67:660669.

    • Search Google Scholar
    • Export Citation
  • 101

    PowEHKwongDLMcMillanAS. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys2006;66:981991.

    • Search Google Scholar
    • Export Citation
  • 102

    KamMKLeungSFZeeB. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol2007;25:48734879.

    • Search Google Scholar
    • Export Citation
  • 103

    PfisterDCassilethBDengG. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. J Clin Oncol2010;28:25652570.

    • Search Google Scholar
    • Export Citation
  • 104

    ScarantinoCLeVequeFSwannRS. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients. J Support Oncol2006;4:252258.

    • Search Google Scholar
    • Export Citation
  • 105

    PetroneDCondemiJJFifeR. A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren’s syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum2002;46:748754.

    • Search Google Scholar
    • Export Citation
  • 106

    GalvinJMDe NeveW. Intensity modulating and other radiation therapy devices for dose painting. J Clin Oncol2007;25:924930.

  • 107

    LauveAMorrisMSchmidt-UllrichR. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II—clinical results. Int J Radiat Oncol Biol Phys2004;60:374387.

    • Search Google Scholar
    • Export Citation
  • 108

    SchoenfeldGOAmdurRJMorrisCG. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys2008;71:377385.

    • Search Google Scholar
    • Export Citation
  • 109

    LeeNYde ArrudaFFPuriDR. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys2006;66:966974.

    • Search Google Scholar
    • Export Citation
  • 110

    de ArrudaFFPuriDRZhungJ. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys2006;64:363373.

    • Search Google Scholar
    • Export Citation
  • 111

    GardenASMorrisonWHWongPF. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys2007;67:438444.

    • Search Google Scholar
    • Export Citation
  • 112

    EisbruchALevendagPCFengFY. Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences. Int J Radiat Oncol Biol Phys2007;69:S4042.

    • Search Google Scholar
    • Export Citation
  • 113

    WoldenSLChenWCPfisterDG. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys2006;64:5762.

    • Search Google Scholar
    • Export Citation
  • 114

    MadaniIBonteKVakaetL. Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update. Int J Radiat Oncol Biol Phys2009;73:424432.

    • Search Google Scholar
    • Export Citation
  • 115

    EisbruchA. Reducing xerostomia by IMRT: what may, and may not, be achieved. J Clin Oncol2007;25:48634864.

  • 116

    HodgeCWBentzenSMWongG. Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparison. Int J Radiat Oncol Biol Phys2007;69:10321041.

    • Search Google Scholar
    • Export Citation
  • 117

    VeldemanLMadaniIHulstaertF. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol2008;9:367375.

    • Search Google Scholar
    • Export Citation
  • 118

    EisbruchAMarshLHDawsonLA. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys2004;59:2842.

    • Search Google Scholar
    • Export Citation
  • 119

    RosenthalDITrottiA. Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol2009;19:2934.

  • 120

    GomezDRZhungJEGomezJ. Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. Int J Radiat Oncol Biol Phys2009;73:10961103.

    • Search Google Scholar
    • Export Citation
  • 121

    LeeNYO’MearaWChanK. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys2007;69:459468.

    • Search Google Scholar
    • Export Citation
  • 122

    NuttingCMMordenJPHarringtonKJ. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol201112:127136.

    • Search Google Scholar
    • Export Citation
  • 123

    NuttingCA’HernRRogersMS. First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005) [abstract]. J Clin Oncol2009;27(Suppl 18):Abstract LBA6006.

    • Search Google Scholar
    • Export Citation
  • 124

    PosnerMRErvinTJMillerD. Incidence of hypothyroidism following multimodality treatment for advanced squamous cell cancer of the head and neck. Laryngoscope1984;94:451454.

    • Search Google Scholar
    • Export Citation
  • 125

    FlemingAJJrSmithSPJrPaulCM. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Laryngoscope2007;117:11731179.

    • Search Google Scholar
    • Export Citation
  • 126

    BranstetterBFBlodgettTMZimmerLA. Head and neck malignancy: is PET/CT more accurate than PET or CT alone?Radiology2005;235:580586.

  • 127

    NasmanAAttnerPHammarstedtL. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?Int J Cancer2009;125:362366.

    • Search Google Scholar
    • Export Citation
  • 128

    HammarstedtLLindquistDDahlstrandH. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer2006;119:26202623.

    • Search Google Scholar
    • Export Citation
  • 129

    AngKKHarrisJWheelerR. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med2010;363:2435.

  • 130

    FakhryCWestraWHLiS. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst2008;100:261269.

    • Search Google Scholar
    • Export Citation
  • 131

    GillisonMLHarrisJWestraW. Survival outcomes by tumor human papillomavirus (HPV) status in stage III-IV oropharyngeal cancer (OPC) in RTOG 0129 [abstract]. J Clin Oncol2009;27(Suppl 15):Abstract 6003.

    • Search Google Scholar
    • Export Citation
  • 132

    RischinDYoungRFisherR. Prognostic significance of HPV and p16 status in patients with oropharyngeal cancer treated on a large international phase III trial [abstract]. J Clin Oncol2009;27(Suppl 15):Abstract 6004.

    • Search Google Scholar
    • Export Citation
  • 133

    LassenPEriksenJGHamilton-DutoitS. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol2009;27:19921998.

    • Search Google Scholar
    • Export Citation
  • 134

    RaginCCTaioliE. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer2007;121:18131820.

    • Search Google Scholar
    • Export Citation
  • 135

    RischinDYoungRJFisherR. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol2010;28:41424148.

    • Search Google Scholar
    • Export Citation
  • 136

    BegumSGillisonMLNicolTLWestraWH. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res2007;13:11861191.

    • Search Google Scholar
    • Export Citation
  • 137

    VokesEEStensonKRosenFR. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol2003;21:320326.

    • Search Google Scholar
    • Export Citation
  • 138

    HittRGrauJLopez-PousaA. Phase II/III trial of induction chemotherapy (ICT) with cisplatin/5-fluorouracil (PF) vs. docetaxel (T) plus PF (TPF) followed by chemoradiotherapy (CRT) vs. CRT for unresectable locally advanced head and neck cancer (LAHNC) [abstract]. J Clin Oncol2005;23(Suppl 16):Abstract 5578.

    • Search Google Scholar
    • Export Citation
  • 139

    HittRLopez-PousaAMartinez-TruferoJ. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol2005;23:86368645.

    • Search Google Scholar
    • Export Citation
  • 140

    HittRGrauJLopez-PousaA. Randomized phase II/III clinical trial of induction chemotherapy (ICT) with either cisplatin/5-fluorouracil (PF) or docetaxel/cisplatin/5-fluorouracil (TPF) followed by chemoradiotherapy (CRT) vs. crt alone for patients (pts) with unresectable locally advanced head and neck cancer (LAHNC) [abstract]. J Clin Oncol2006;24(Suppl 18):Abstract 5515.

    • Search Google Scholar
    • Export Citation
  • 141

    PosnerMRHershockDMBlajmanCR. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med2007;357:17051715.

    • Search Google Scholar
    • Export Citation
  • 142

    PignonJPBourhisJDomengeCDesigneL. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet2000;355:949955.

    • Search Google Scholar
    • Export Citation
  • 143

    PaccagnellaAOrlandoAMarchioriC. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst1994;86:265272.

    • Search Google Scholar
    • Export Citation
  • 144

    LorchJHGoloubevaOHaddadRI. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol2011;12:152159.

    • Search Google Scholar
    • Export Citation
  • 145

    VermorkenJBRemenarEvan HerpenC. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med2007;357:16951704.

    • Search Google Scholar
    • Export Citation
  • 146

    PignonJPle MaitreAMaillardEBourhisJ. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol2009;92:414.

    • Search Google Scholar
    • Export Citation
  • 147

    LefebvreJLChevalierDLuboinskiB. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst1996;88:890899.

    • Search Google Scholar
    • Export Citation
  • 148

    Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med1991;324:16851690.

    • Search Google Scholar
    • Export Citation
  • 149

    McNeilBJWeichselbaumRPaukerSG. Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med1981;305:982987.

    • Search Google Scholar
    • Export Citation
  • 150

    AdelsteinDJLiYAdamsGL. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol2003;21:9298.

    • Search Google Scholar
    • Export Citation
  • 151

    LoTCWileyALJrAnsfieldFJ. Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study. AJR Am J Roentgenol1976;126:229235.

    • Search Google Scholar
    • Export Citation
  • 152

    SanchizFMillaATornerJ. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys1990;19:13471350.

    • Search Google Scholar
    • Export Citation
  • 153

    BrowmanGPCrippsCHodsonDI. Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol1994;12:26482653.

    • Search Google Scholar
    • Export Citation
  • 154

    SmidLLesnicarHZakotnikB. Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer—preliminary report. Int J Radiat Oncol Biol Phys1995;32:769775.

    • Search Google Scholar
    • Export Citation
  • 155

    MerlanoMBenassoMCorvoR. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst1996;88:583589.

    • Search Google Scholar
    • Export Citation
  • 156

    WendtTGGrabenbauerGGRodelCM. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol1998;16:13181324.

    • Search Google Scholar
    • Export Citation
  • 157

    MunroAJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer1995;71:8391.

  • 158

    El-SayedSNelsonN. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol1996;14:838847.

    • Search Google Scholar
    • Export Citation
  • 159

    BourhisJAmandCPignonJP. Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy [abstract]. J Clin Oncol2004;22(Suppl 14):Abstract 5505.

    • Search Google Scholar
    • Export Citation
  • 160

    PignonJPle MaitreABourhisJ. Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys2007;69:S112114.

    • Search Google Scholar
    • Export Citation
  • 161

    ForastiereAAGoepfertHMaorM. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med2003;349:20912098.

    • Search Google Scholar
    • Export Citation
  • 162

    ArgirisAHarafDJKiesMSVokesEE. Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure. Oncologist2003;8:350360.

    • Search Google Scholar
    • Export Citation
  • 163

    PointreauYGaraudPChapetS. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst2009;101:498506.

    • Search Google Scholar
    • Export Citation
  • 164

    PaccagnellaAGhiMGLoreggianL. Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. Ann Oncol2010;21:15151522.

    • Search Google Scholar
    • Export Citation
  • 165

    HittRGrauJJLopez-PousaA. Final results of a randomized phase III trial comparing induction chemotherapy with cisplatin/5-FU or docetaxel/cisplatin/5-FU follow by chemoradiotherapy (CRT) versus CRT alone as first-line treatment of unresectable locally advanced head and neck cancer (LAHNC) [abstract]. J Clin Oncol2009;27(Suppl 15):Abstract 6009.

    • Search Google Scholar
    • Export Citation
  • 166

    SalamaJKHaddadRIKiesMS. Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys2009;75:725733.

    • Search Google Scholar
    • Export Citation
  • 167

    LefebvreJPointreauYRollandF. Sequential chemoradiotherapy (SCRT) for larynx preservation (LP): preliminary results of the randomized phase II TREMPLIN study [abstract]. J Clin Oncol2009;27(Suppl 15):Abstract 6010.

    • Search Google Scholar
    • Export Citation
  • 168

    BuiretGCombeCFavrelV. A retrospective, multicenter study of the tolerance of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil followed by radiotherapy with concomitant cetuximab in 46 cases of squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys2010;77:430437.

    • Search Google Scholar
    • Export Citation
  • 169

    NuttingCMBhideSAHarringtonKJ. Treatment of head and neck cancer. N Engl J Med2008;358:10761077; author reply 1077–1078.

  • 170

    ChitapanaruxILorvidhayaVKamnerdsupaphonP. Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomised, non-inferiority, open trial. Eur J Cancer2007;43:13991406.

    • Search Google Scholar
    • Export Citation
  • 171

    KiesMSHolsingerFCLeeJJ. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol2010;28:814.

    • Search Google Scholar
    • Export Citation
  • 172

    KotwallCSakoKRazackMS. Metastatic patterns in squamous cell cancer of the head and neck. Am J Surg1987;154:439442.

  • 173

    LefebvreJLRollandFTesselaarM. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst2009;101:142152.

    • Search Google Scholar
    • Export Citation
  • 174

    CooperJSdel RoweJNewallJ. Regional stage IV carcinoma of the nasopharynx treated by aggressive radiotherapy. Int J Radiat Oncol Biol Phys1983;9:17371745.

    • Search Google Scholar
    • Export Citation
  • 175

    BailetJWMarkRJAbemayorE. Nasopharyngeal carcinoma: treatment results with primary radiation therapy. Laryngoscope1992;102:965972.

  • 176

    JohansenLVMestreMOvergaardJ. Carcinoma of the nasopharynx: analysis of treatment results in 167 consecutively admitted patients. Head Neck1992;14:200207.

    • Search Google Scholar
    • Export Citation
  • 177

    SanguinetiGGearaFBGardenAS. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys1997;37:985996.

    • Search Google Scholar
    • Export Citation
  • 178

    WangC. Radiation Therapy for Head and Neck Neoplasms3rd ed.New York, NY: Wiley-Liss; 1997.

  • 179

    Al-SarrafMLeBlancMGiriPG. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol1998;16:13101317.

    • Search Google Scholar
    • Export Citation
  • 180

    MesicJBFletcherGHGoepfertH. Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys1981;7:447453.

    • Search Google Scholar
    • Export Citation
  • 181

    HoppeRTGoffinetDRBagshawMA. Carcinoma of the nasopharynx. Eighteen years’ experience with megavoltage radiation therapy. Cancer1976;37:26052612.

    • Search Google Scholar
    • Export Citation
  • 182

    WeeJTanEHTaiBC. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol2005;23:67306738.

    • Search Google Scholar
    • Export Citation
  • 183

    ChanATLeungSFNganRK. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst2005;97:536539.

    • Search Google Scholar
    • Export Citation
  • 184

    LeongSSWeeJTayMH. Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: a phase II trial using a triplet combination. Cancer2005;103:569575.

    • Search Google Scholar
    • Export Citation
  • 185

    ChanATHsuMMGohBC. Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. J Clin Oncol2005;23:35683576.

    • Search Google Scholar
    • Export Citation
  • 186

    ZhangLZhangYHuangPY. Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy. Cancer Chemother Pharmacol2008;61:3338.

    • Search Google Scholar
    • Export Citation
  • 187

    NganRKYiuHHLauWH. Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study. Ann Oncol2002;13:12521258.

    • Search Google Scholar
    • Export Citation
  • 188

    MaBBTannockIFPondGR. Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma. Cancer2002;95:25162523.

    • Search Google Scholar
    • Export Citation
  • 189

    BonnerJAHarariPMGiraltJ. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med2006;354:567578.

  • 190

    GardenASHarrisJVokesEE. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol2004;22:28562864.

    • Search Google Scholar
    • Export Citation
  • 191

    GardenASHarrisJVokesEE. Results of Radiation Therapy Oncology Group 97-03—a randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck: long-term results and late toxicities [abstract]. Int J Radiat Oncol Biol Phys2007;69:S140.

    • Search Google Scholar
    • Export Citation
  • 192

    VermorkenJBTrigoJHittR. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. J Clin Oncol2007;25:21712177.

    • Search Google Scholar
    • Export Citation
  • 193

    ColevasAD. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol2006;24:26442652.

    • Search Google Scholar
    • Export Citation
  • 194

    ForastiereAAShankDNeubergD. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390). Cancer1998;82:22702274.

    • Search Google Scholar
    • Export Citation
  • 195

    GibsonMKLiYMurphyB. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol2005;23:35623567.

    • Search Google Scholar
    • Export Citation
  • 196

    ForastiereAAMetchBSchullerDE. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. J Clin Oncol1992;10:12451251.

    • Search Google Scholar
    • Export Citation
  • 197

    VermorkenJBMesiaRRiveraF. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med2008;359:11161127.

  • 198

    SamlowskiWEMoonJKueblerJP. Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): a Southwest Oncology Group phase II study. Cancer Invest2007;25:182188.

    • Search Google Scholar
    • Export Citation
  • 199

    BurtnessBGoldwasserMAFloodW. Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol2005;23:86468654.

    • Search Google Scholar
    • Export Citation
  • 200

    JacobsCLymanGVelez-GarciaE. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol1992;10:257263.

    • Search Google Scholar
    • Export Citation
  • 201

    BrowmanGPCroninL. Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trials. Semin Oncol1994;21:311319.

    • Search Google Scholar
    • Export Citation
  • 202

    ClavelMVermorkenJBCognettiF. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group. Ann Oncol1994;5:521526.

    • Search Google Scholar
    • Export Citation
  • 203

    StewartJSCohenEELicitraL. Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected]. J Clin Oncol2009;27:18641871.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 580 580 35
PDF Downloads 68 68 3
EPUB Downloads 0 0 0